Le Lézard
Classified in: Health
Subject: SVY

Seasonal Influenza Vaccines Markets, 2017-2018 to 2016-2027 - Differentiated Vaccines Targeting Specific Population Subgroups will See Significant Uptake


DUBLIN, June 18, 2019 /PRNewswire/ -- The "Seasonal Influenza Vaccines" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Seasonal influenza is an acute viral infection that is spread by person-to-person transmission. Influenza, commonly referred to as the flu, circulates worldwide and can affect anyone in any age group, although annual epidemics peak during winter in temperate climates. Seasonal influenza can be type A, B, or C. Type A influenza viruses are considered to be the most virulent of the three types, and can be further classified by serotype based on antibody response to the virus.

Market Snapshot

Key Topics Covered:

FORECAST: SEASONAL INFLUENZA VACCINES
Overview
Recent Forecast Updates
Market Overview And Trends
Key Drivers And Resistors Of Conversion To Qivs
Market Definition And Methodology
US Market Forecast
France Market Forecast
Germany Market Forecast
Italy Market Forecast
Spain Market Forecast
UK Market Forecast
Primary Research Methodology

MARKETED DRUGS: SEASONAL INFLUENZA VACCINES (Published on 10 January 2019)
Overview
Product Overview
Inactivated Vaccines
Product Profile: Flumist Qiv
Product Profile: Flublok
Product Profile: Flucelvax Qiv
Product Profile: Fluzone High-Dose

PIPELINE: SEASONAL INFLUENZA VACCINES (Published on 10 January 2019)
Overview
Clinical Pipeline Overview
Universal Influenza Vaccines
Additional Pharma Intelligence Pipeline Resources
Product Profile (Late Stage): Fluad Qiv
Product Profile (Late Stage): Mt-2271

For more information about this report visit https://www.researchandmarkets.com/r/k7891q

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:


Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 13:12
Empowered by employee donations and matched by management contributions, Radians® quarterly Tickets for Charity (TFC) program champions local Memphis and Midsouth charities, offering crucial support for sustaining daily operations and expanding their...

at 13:07
Multi-award-winning Civil Rights Attorney and Child Advocate, Areva Martin, in collaboration with the Special Needs Network (SNN), has revealed the distinguished honorees for the 16th Annual A Pink Pump Affair. This noteworthy charity event is...

at 13:05
Convergent Dental, the power behind the Solea® All-Tissue Dental Laser, proudly announces the rebranding of its annual customer event from the "Solea User Group Meeting" to the "Solea Summit." This update reflects the evolution of the event into the...

at 13:00
The Laniado Hospital in Netanya, Israel, is embarking on a crucial initiative to construct the country's first fully sheltered emergency care building. With the support of the Laniado Development Fund, this endeavor aims to enhance public healthcare...

at 13:00
Ocenture, a prominent player in Telemedicine and private label development for three decades, proudly announces a partnership with Iron Remedy MD, a concierge healthcare company founded by Ocenture and iconic boxing legend, entertainer, and serial...

at 12:52
As part of Tampa General Hospital's (TGH) commitment to transforming health care through innovation, the academic health system collaborated with Manatee County and Archer First Response Systems (ArcherFRS) to accelerate response times to...



News published on and distributed by: